ANKRD30A and breast carcinoma: LncRNA CTD-3032H12.1 is predicted to interact with another lncRNA RP11-20F24.2 and mRNA of ANKRD30A, a transcription factor implicated in breast cancer progression, using a tissue-specific co-expression regulatory network model [75].